| R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026 |
Globe Newswire |
10/15 |
07:00 |
| PlaneSense to equip entire fleet of PC-12 turboprops and PC-24 Jets with Gogo Galileo connectivity |
Globe Newswire |
10/15 |
07:00 |
| Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab |
Globe Newswire |
10/15 |
07:00 |
| First Advantage to Release Third Quarter 2026 Financial Results and Hold Investor Conference Call on November 5, 2026 |
Globe Newswire |
10/15 |
07:00 |
| Origin Launches Stress-Tolerant Corn Breeding for Southwest China Markets, with Supports from Guizhou State Entities |
Globe Newswire |
10/15 |
07:00 |
| PyroGenesis Completes Seven-System Drosrite™ Deployment at World’s Largest Aluminum Complex |
Globe Newswire |
10/15 |
07:00 |
| Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes |
Globe Newswire |
10/15 |
07:00 |
| Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 |
Globe Newswire |
10/15 |
07:00 |
| INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS |
Globe Newswire |
10/15 |
07:00 |
| Salvia BioElectronics Initiates Pivotal Study with First Patient in the U.S. Receiving Ultra Thin Neuromodulation Implant for Resistant Migraine |
Globe Newswire |
10/15 |
07:00 |
| Brunswick Exploration Announces 302 Metre-Wide Spodumene-Bearing Pegmatite Interval at the Anatacau Main Project |
Globe Newswire |
10/15 |
07:00 |
| ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process |
Globe Newswire |
10/15 |
07:00 |
| Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company |
Globe Newswire |
10/15 |
07:00 |
| Plug Power Reports Continued Business Progress, Sets Dates for Third Quarter 2026 Earnings Call and Global Plug Symposium |
Globe Newswire |
10/15 |
07:00 |
| Why Is Weight Loss Different During Menopause? Common Myths Debunked |
Globe Newswire |
10/15 |
07:00 |
| Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026 |
Globe Newswire |
10/15 |
07:00 |
| Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026 |
Globe Newswire |
10/15 |
07:00 |
| Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME) |
Globe Newswire |
10/15 |
07:00 |
| REGO Payment Architectures Launches REGO Guardian Global Child-Safety SaaS Licensing Infrastructure, Starting with the $121 Billion Mobile Gaming Industry |
Globe Newswire |
10/15 |
06:59 |
| Aegon completes exchange of all Common Shares B for common stock |
Globe Newswire |
10/15 |
06:45 |
| LEPAS L6 EV to Embark on LEPAS Global Elegance Drive: Real Roads, Real Driving Dynamics |
Globe Newswire |
10/15 |
06:41 |
| Northland’s Hai Long Offshore Wind Project Reaches Major Milestone: All 73 Turbines Installed and Generating Power |
Globe Newswire |
10/15 |
06:39 |
| Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd. Attorneys File Securities Class Action Against Compass, Inc. (NYSE: COMP) |
Globe Newswire |
10/15 |
06:30 |
| Westport Rebrands as Aetherion™ Technologies, Focused on Accelerating Proven Solutions for Heavy-Duty Clean Transport |
Globe Newswire |
10/15 |
06:30 |
| The Human Advantage Conference 2026: Navigating a complex world through Behavioural Science, AI and Human Intelligence |
Globe Newswire |
10/15 |
06:24 |
